Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadobutrol vs Magnevist for Body/Extremities MRI
NCT01050829Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of gadobutrol, sponsored by Bayer. Started Jan 2010; status: completed.
02
Drugs
gadobutrol
Beyond the preview
Go deeper on NCT01050829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050829.